![A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/592dc2d8-d9c8-44c8-b3e0-18b7bb3be1c6/gr1_lrg.jpg)
A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine
![Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 - Annals of Oncology Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/92cdb022-7df4-45ab-861e-09c65062be4a/gr1_lrg.jpg)
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 - Annals of Oncology
![Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) - Journal of Thoracic Oncology Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/49cd6e8f-4319-457e-af00-4dbbab967dfb/gr1.jpg)
Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) - Journal of Thoracic Oncology
![Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-018-0155-7/MediaObjects/41408_2018_155_Fig1_HTML.png)
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
![Clinically meaningful benefit: real world use compared against the American and European guidelines | Blood Cancer Journal Clinically meaningful benefit: real world use compared against the American and European guidelines | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-017-0009-8/MediaObjects/41408_2017_9_Fig1_HTML.gif)
Clinically meaningful benefit: real world use compared against the American and European guidelines | Blood Cancer Journal
![Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non–Small Cell Lung Cancer - Journal of Thoracic Oncology Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non–Small Cell Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/22d0423f-4272-4fdd-b4c5-1abefe055483/gr2_lrg.jpg)
Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non–Small Cell Lung Cancer - Journal of Thoracic Oncology
![Definition of progression free survival and overall survival for the... | Download Scientific Diagram Definition of progression free survival and overall survival for the... | Download Scientific Diagram](https://www.researchgate.net/publication/265644752/figure/fig1/AS:269802786783234@1441337405030/Definition-of-progression-free-survival-and-overall-survival-for-the-Gold-standard-and_Q320.jpg)
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
![Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials | BMJ Open Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/3/3/e001802/F1.large.jpg?width=800&height=600&carousel=1)
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials | BMJ Open
![Frontiers | Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors | Oncology Frontiers | Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors | Oncology](https://www.frontiersin.org/files/Articles/464476/fonc-09-00453-HTML/image_m/fonc-09-00453-g001.jpg)
Frontiers | Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors | Oncology
![Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of](https://ars.els-cdn.com/content/image/1-s2.0-S0959804914008727-gr1.jpg)
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
![Kaplan-Meier overall survival (OS) functions are illustrated. Patients... | Download Scientific Diagram Kaplan-Meier overall survival (OS) functions are illustrated. Patients... | Download Scientific Diagram](https://www.researchgate.net/profile/Jochen-Lorch/publication/51727572/figure/fig1/AS:277568352735235@1443188860176/Kaplan-Meier-overall-survival-OS-functions-are-illustrated-Patients-are-grouped-based.png)
Kaplan-Meier overall survival (OS) functions are illustrated. Patients... | Download Scientific Diagram
![Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience](https://assets.cureus.com/uploads/figure/file/56884/lightbox_96799eb01b4f11e9836e8ffceb76b5f5-Figure-1.png)
Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience
![Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival - Journal of Hepatology Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9a9d6471-981e-443b-a53a-2062659734ab/gr1_lrg.jpg)
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival - Journal of Hepatology
![Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12916-018-1120-9/MediaObjects/12916_2018_1120_Fig1_HTML.png)